# Meropenem

NDC: 81962-002
Generic name: Meropenem
Labeler / Manufacturer: BROOKS STERISCIENCE LIMITED
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION
Routes: INTRAVENOUS
Marketing started: 20250627

FDA application: ANDA219084

## Active ingredients

- MEROPENEM ANHYDROUS: 2 g/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"81962-002"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=81962-002
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6902fee1-6022-4145-a79a-4680ad1fb1e8